Kevin Franciotti



Science writer, graduate student researcher and aspiring clinician, harm reduction educator and substance use recovery advocate

If you wish to get in touch, please email or say hi on LinkedIn.

View Articles

Featured Articles

After Prince’s Tragic Overdose, Here’s What You Need to Know About Fentanyl.The toxicology results from music legend Prince’s tragic death last month are now public, and the media are focusing on what for many is a new word: fentanyl. It appears likely that Prince ingested it and tragically died some time later

After Prince’s Tragic Overdose, Here’s What You Need to Know About Fentanyl

The toxicology results from music legend Prince’s tragic death last month are now public, and the media are focusing on what for many is a new word: fentanyl. It appears likely that Prince ingested it and tragically died some time later...
Inside a Music Festival in a Country Where All Drugs Are Decriminalized. Boom Festival, a biennial gathering held near the Spanish border, about 100 volunteers committed to round-the-clock care for people using drugs.

Inside a Music Festival in a Country Where All Drugs Are Decriminalized

At the Boom Festival, a biennial gathering held near the Spanish border last month, about 100 volunteers committed to round-the-clock care for people using drugs. I was one of them. If you've been to a mainstream music festival in Sweden...
Psychedelic Science Despite steep regulatory barriers, researchers are exploring the therapeutic possibilities of ecstasy, acid, and mushrooms

Psychedelic Science


In the 1950s and '60s, psychedelic drug research seemed to offer promising paths for treating schizophrenia, obsessive-compulsive disorder, alcoholism, and other disorders. The Controlled Substances Act of 1970 interrupted legitimate...
When the Drug Enforcement Administration decides it really doesn't like a drug, your odds of learning anything useful about it become very, very slim. Take marijuana, for instance: The DEA still classifies it as a schedule 1 substance, which means it has no recognized medical use and a high potential for abuse.

Club Drugs Are Having a Moment


When the Drug Enforcement Administration decides it really doesn't like a drug, your odds of learning anything useful about it become very, very slim. Take marijuana, for instance: The DEA still classifies it as a schedule 1 substance...
Magic mushroom drug helps people with cancer face death

Magic mushroom drug helps people with cancer face death

Can a psychedelic trip change the way people with life-threatening cancer face death? Results from two clinical trials suggest so. Researchers have shown that a single dose of psilocybin – the active ingredient in magic mushrooms – combined with...

Swiss psychiatrist Peter Gasser received permission from his government to use acid in his practice, which he says can help people deal with anxiety and fear of death

Meet the Only Doctor in the World Legally Allowed to Use LSD to Treat Patients

Last year, Swiss psychiatrist Peter Gasser received permission from his government to use acid in his practice, which he says can help people deal with anxiety and fear of death, among other things...

Kevin Franciotti received his bachelor of science degree from Northeastern University in 2013. In addition to his undergraduate study of behavioral neuroscience, he completed internships for a mental health rehabilitation agency serving clients in the Boston community, and at Harvard Medical School’s McLean Hospital, assisting in a psychedelic research lab. Kevin helped found the Northeastern chapter of Students for Sensible Drug Policy, where the group hosted and co-sponsored the Boston Ibogaine Forum. As an associate for the Drug Policy Alliance, Kevin researched, drafted, and facilitated the peer-review of five drug fact sheets, and he regularly contributes as an independent writer, where his articles have appeared in New Scientist magazine and VICE.com. He is now based in New York City enrolled in the graduate psychology program at The New School for Social Research. Kevin is focusing his learning and career objectives on the study and practice of mental health and substance use counseling, with a research focus on the effects of non-medical psychedelic substance use on wellbeing and other mental health outcomes, and in clinical contexts for drug-assisted psychotherapy.

Contact